Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

wsj.com - Adrià Calatayud - Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion
Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion
Wall Street Journal –

said it plans to spend $2.2 billion to build a new manufacturing site in Ohio for its pharmaceutical business, becoming the latest European drugmaker to invest in the U.S. The German agricultural and pharmaceutical group said Friday that its new…

wsj.com - Adrià Calatayud - Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion
Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion
Wall Street Journal –

The German company's pharma business has been looking to expand in the U.S., betting that an enlarged presence in the world's largest drug market can help it revive sales growth after two key products went off patent.

thehindubusinessline.com - Aurobindo Pharma: Strong Dose of Growth Opportunities
Aurobindo Pharma: Strong Dose of Growth Opportunities
BusinessLine –

Aurobindo Pharma has developed multiple growth opportunities which should play out both in the long term and short term. As the company has commercialised most ventures, its risk reward is getting more favourable and may offer value for investors…

cyclingnews.com - Simone Giuliani - We are a family, and it's really sad' - Nil Gimeno delivers a first win at Le Tour de Langkawi but it could well be Kern Pharma's last
We are a family, and it's really sad' - Nil Gimeno delivers a first win at Le Tour de Langkawi but it could well be Kern Pharma's last
Cyclingnews –

A first win always means a lot, though somehow this one seems like it may mean that bit more, as when Nil Gimeno took his victory on stage 7 of Le Tour de Langkawi it was not just a beginning, but also potentially an end. It was announced earlier…

marketbeat.com - Avalyn Pharma (NASDAQ:AVLN) Upgraded at Raymond James Financial
Avalyn Pharma (NASDAQ:AVLN) Upgraded at Raymond James Financial
MarketBeat –

Avalyn Pharma (NASDAQ:AVLN - Get Free Report) was upgraded by equities researchers at Raymond James Financial to a 'moderate buy' rating in a research report issued on Friday, Zacks reports. Other research analysts also recently issued research…

marketbeat.com - Spyglass Pharma (NASDAQ:SGP) Stock Moved Down to Sell by Wall Street Zen
Spyglass Pharma (NASDAQ:SGP) Stock Moved Down to Sell by Wall Street Zen
MarketBeat –

Spyglass Pharma (NASDAQ:SGP - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a 'hold' rating to a 'sell' rating in a note issued to investors on Saturday, Wall Street Zen reports. SGP has been the topic of a number…

marketbeat.com - Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells $1,257,657.38 in Stock
Insider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells $1,257,657.38 in Stock
MarketBeat –

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Kastelein sold 50,246 shares of the stock in a transaction dated Wednesday, September 30th. The stock was sold at an average price of $25.03, for a total transaction…

seekingalpha.com - Albert Anthony - Alaska Air In Holding Pattern For Now, Fuel Cost Dominating The Risk Story (NYSE:ALK)
Alaska Air In Holding Pattern For Now, Fuel Cost Dominating The Risk Story (NYSE:ALK)
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

thehindu.com - Nandini Raman - Identify a mentor
Identify a mentor
The Hindu –

I have completed my UG degree and have a strong desire to clear the TNPSC exam, but feel lazy and demotivated. How can I build a consistent study habit? Nithiyasri Are you sure you are not overwhelmed by the massive syllabus? First, confirm that…

cyclingnews.com - Simone Giuliani - Nil Gimeno snares first professional win at stage 7 of Le Tour de Langkawi to Batu Pahat
Nil Gimeno snares first professional win at stage 7 of Le Tour de Langkawi to Batu Pahat
Cyclingnews –

Nil Gimeno (Equipo Kern Pharma) took his first professional victory on stage 7 of Le Tour de Langkawi to Batu Pahat, as the break of four prevailed despite a charged pursuit by the sprinters teams. Gimeno, who was a frustrating fourth on stage 4…

fool.com - Robert Izquierdo - Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
The Motley Fool –

The VanEck Pharmaceutical ETF (PPH -0.07%) provides a lower-cost entry and higher yield than the Invesco Pharmaceuticals ETF (PJP -0.30%), which has shown stronger 1-year returns and more concentrated top holdings. These ETFs target the…

fool.com - Prosper Junior Bakiny - Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investors
Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investors
The Motley Fool –

Novo Nordisk (NVO -0.21%) is looking to maintain its position in the weight-loss market and one-up its most important competitor, Eli Lilly (LLY -0.61%). To that end, the Denmark-based pharmaceutical giant has developed several promising…

thehindubusinessline.com - Russia to take 70,000 Indian skilled workers this year, Jaishankar tells parliamentary panel
Russia to take 70,000 Indian skilled workers this year, Jaishankar tells parliamentary panel
BusinessLine –

External Affairs Minister S Jaishankar on Saturday briefed a parliamentary consultative committee on India's “multifaceted” engagement with Russia, highlighting shared ambitions to expand bilateral trade, investment, and energy…

foxbusiness.com - Michael Dorgan - Trump's investment push hits Europe as Irish PM eyes next tariff break
Trump's investment push hits Europe as Irish PM eyes next tariff break
Fox Business –

NEW YORK – As President Donald Trump pushes U.S. multinationals to expand investment at home, Irish Prime Minister Micheál Martin is pitching Ireland as a leading European hub for American investment while already eyeing another…

marketbeat.com - Astrazeneca (NYSE:AZN) Upgraded to Buy at Wall Street Zen
Astrazeneca (NYSE:AZN) Upgraded to Buy at Wall Street Zen
MarketBeat –

Astrazeneca (NYSE:AZN - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a 'hold' rating to a 'buy' rating in a research note issued on Saturday, Wall Street Zen reports. The Phase 3 Failure That Sent Biotech Winners…

Receive a Daily briefing on Pharma Industry News

Get Started